Cell Reports · 2017 · 165 citations · 30 references
MedicineOncologyPharmacologyMolecular ImagingMolecular OncologyPrecision OncologyCancer MetabolismLung Cancer PharmacotherapyMetabolic ReprogrammingMetabolic Reprogramming In CancerOncogenic Signaling PathwaysTumor ImagingEgfr InhibitionEpidermal Growth Factor Receptor InhibitionErlotinib TherapyGlutamine MetabolismNon-small Cell Lung Cancer ImagingNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentTumor Metabolism
C-Gln tracers can be used to non-invasively measure metabolic response to CB-839 and erlotinib combination therapy.
30
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.6K citations
Medicine, Oncology, Pharmacology +13
David R. Wise, Ralph J. DeBerardinis, Anthony Mancuso et al. · Proceedings of the National Academy of Sciences · 2008 · 2K citations · Full text
Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
Christian M. Metallo, Paulo A. Gameiro, Eric L. Bell et al. · Nature · 2011 · 1.8K citations · Full text